141 related articles for article (PubMed ID: 28086239)
1. Elevated fibrous sheath interacting protein 1 levels are associated with poor prognosis in non-small cell lung cancer patients.
Mao Y; Xu R; Liu X; Shi W; Han Y
Oncotarget; 2017 Feb; 8(7):12186-12193. PubMed ID: 28086239
[TBL] [Abstract][Full Text] [Related]
2. FSIP1 is correlated with estrogen receptor status and poor prognosis.
Li X; Song X; Ma J; Zhao Y; Jiang Q; Zhao Z; Li M
Mol Carcinog; 2020 Jan; 59(1):126-135. PubMed ID: 31713931
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer.
Xu CH; Sheng ZH; Hu HD; Hao KK; Wang QB; Yu LK
Tumour Biol; 2014 Sep; 35(9):8673-8. PubMed ID: 24870591
[TBL] [Abstract][Full Text] [Related]
4. Positive association between aspirin-intolerant asthma and genetic polymorphisms of FSIP1: a case-case study.
Kim JY; Kim JH; Park TJ; Bae JS; Lee JS; Pasaje CF; Park BL; Cheong HS; Park JS; Park SW; Uh ST; Kim MK; Choi IS; Cho SH; Choi BW; Park CS; Shin HD
BMC Pulm Med; 2010 Jun; 10():34. PubMed ID: 20513247
[TBL] [Abstract][Full Text] [Related]
5. FSIP1 Is Associated with Poor Prognosis and Can Be Used to Construct a Prognostic Model in Gastric Cancer.
Yan X; Dai J; Han Y; You Q; Liu Y
Dis Markers; 2022; 2022():2478551. PubMed ID: 35692888
[TBL] [Abstract][Full Text] [Related]
6. Expression and clinicopathological significance of FSIP1 in breast cancer.
Zhang H; Luo M; Jin Z; Wang D; Sun M; Zhao X; Zhao Z; Lei H; Li M; Liu C
Oncotarget; 2015 Apr; 6(12):10658-66. PubMed ID: 25826084
[TBL] [Abstract][Full Text] [Related]
7. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
Xing R; Chen KB; Xuan Y; Feng C; Xue M; Zeng YC
Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization.
Yan M; Wang J; Ren Y; Li L; He W; Zhang Y; Liu T; Li Z
Cell Death Dis; 2019 Feb; 10(3):204. PubMed ID: 30814489
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer.
Lu C; Wang X; Zhu H; Feng J; Ni S; Huang J
Oncotarget; 2015 Sep; 6(28):24912-21. PubMed ID: 26305508
[TBL] [Abstract][Full Text] [Related]
10. FSIP1 regulates autophagy in breast cancer.
Liu C; Sun L; Yang J; Liu T; Yang Y; Kim SM; Ou X; Wang Y; Sun L; Zaidi M; New MI; Yuen T; Guo Q
Proc Natl Acad Sci U S A; 2018 Dec; 115(51):13075-13080. PubMed ID: 30509973
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of expression of fibrous sheath interacting protein 1 in colon cancer.
Wu HY; Yang B; Geng DH
World J Gastrointest Oncol; 2020 Jun; 12(6):677-686. PubMed ID: 32699582
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of cancer/testis antigen FSIP1 in ER-positive breast tumors.
Chapman KB; Prendes MJ; Kidd JL; Sternberg H; West MD; Wagner J
Biomark Med; 2013 Aug; 7(4):601-11. PubMed ID: 23905897
[TBL] [Abstract][Full Text] [Related]
14. Fibrous sheath interacting protein 1 overexpression is associated with unfavorable prognosis in bladder cancer: a potential therapeutic target.
Sun M; Zhao W; Zeng Y; Zhang D; Chen Z; Liu C; Wu B
Onco Targets Ther; 2017; 10():3949-3956. PubMed ID: 28860802
[TBL] [Abstract][Full Text] [Related]
15. FSIP1 binds HER2 directly to regulate breast cancer growth and invasiveness.
Liu T; Zhang H; Sun L; Zhao D; Liu P; Yan M; Zaidi N; Izadmehr S; Gupta A; Abu-Amer W; Luo M; Yang J; Ou X; Wang Y; Bai X; Wang Y; New MI; Zaidi M; Yuen T; Liu C
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7683-7688. PubMed ID: 28674022
[TBL] [Abstract][Full Text] [Related]
16. FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway.
Chen G; Sun L; Gu X; Ai L; Yang J; Zhang Z; Hou P; Wang Y; Ou X; Jiang X; Qiao X; Ma Q; Niu N; Xue J; Zhang H; Yang Y; Liu C
Sci China Life Sci; 2023 Dec; 66(12):2805-2817. PubMed ID: 37460715
[TBL] [Abstract][Full Text] [Related]
17. High Sam68 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Xu Y; Sun N; Zhang M; Xie J; Jiang Z
Clin Transl Oncol; 2014 Oct; 16(10):886-91. PubMed ID: 24522888
[TBL] [Abstract][Full Text] [Related]
18. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Guo Y
Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Frat1 correlates with malignant phenotype and advanced stage in human non-small cell lung cancer.
Zhang Y; Yu JH; Lin XY; Miao Y; Han Y; Fan CF; Dong XJ; Dai SD; Wang EH
Virchows Arch; 2011 Sep; 459(3):255-63. PubMed ID: 21818639
[TBL] [Abstract][Full Text] [Related]
20. The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer.
Liu J; Lin Y; Yang H; Deng Q; Chen G; He J
Tumour Biol; 2011 Dec; 32(6):1113-21. PubMed ID: 21779982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
